Literature DB >> 25387613

Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis.

M Goeijenbier1, J J A van Kampen, C B E M Reusken, M P G Koopmans, E C M van Gorp.   

Abstract

Currently, West Africa is facing the largest outbreak of Ebola virus disease (EVD) in history. The virus causing this outbreak, the Zaire Ebolavirus (EBOV), belongs to the genus Ebolavirus which together with the genus Marburgvirus forms the family of the Filoviridae. EBOV is one of the most virulent pathogens among the viral haemorrhagic fevers, and case fatality rates up to 90% have been reported. Mortality is the result of multi-organ failure and severe bleeding complications. By 18 September 2014, the WHO reported of 5335 cases (confirmed, suspected and probable) with 2622 deaths, resulting in a case fatality rate of around 50%. This review aims to provide an overview of EVD for clinicians, with the emphasis on pathogenesis, clinical manifestations, and treatment options.

Entities:  

Mesh:

Year:  2014        PMID: 25387613

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  30 in total

Review 1.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

Review 2.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 3.  Neurological Complications of Ebola Virus Infection.

Authors:  Bridgette Jeanne Billioux; Bryan Smith; Avindra Nath
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Ophthalmic Manifestations and Causes of Vision Impairment in Ebola Virus Disease Survivors in Monrovia, Liberia.

Authors:  Jessica G Shantha; Ian Crozier; Brent R Hayek; Beau B Bruce; Catherine Gargu; Jerry Brown; John Fankhauser; Steven Yeh
Journal:  Ophthalmology       Date:  2016-11-30       Impact factor: 12.079

Review 5.  Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.

Authors:  Azizul Haque; Didier Hober; Joel Blondiaux
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

6.  In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.

Authors:  Sarkar Soumajit; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2019-12-05

7.  Ebola virus disease: from epidemiology to prophylaxis.

Authors:  Wen Bin Liu; Zi Xiong Li; Yan Du; Guang Wen Cao
Journal:  Mil Med Res       Date:  2015-03-10

Review 8.  RNA Virus-Encoded miRNAs: Current Insights and Future Challenges.

Authors:  Asuka Nanbo; Wakako Furuyama; Zhen Lin
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

9.  Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach.

Authors:  Arafat Rahman Oany; Tahmina Sharmin; Afrin Sultana Chowdhury; Tahmina Pervin Jyoti; Md Anayet Hasan
Journal:  In Silico Pharmacol       Date:  2015-08-08

10.  Association of clinical signs and symptoms of Ebola viral disease with case fatality: a systematic review and meta-analysis.

Authors:  Harsha Moole; Swetha Chitta; Darlyn Victor; Manasa Kandula; Vishnu Moole; Harshavardhan Ghadiam; Anusha Akepati; Charan Yerasi; Achuta Uppu; Sowmya Dharmapuri; Raghuveer Boddireddy; Jacqueline Fischer; Teresa Lynch
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.